SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 15, 2026

TNXP

Tonix Pharmaceuticals Holding Corp.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago
Insider cluster: 3 insiders, $0.1M total
Actionable Insight • Neutral

The small insider purchases are unlikely to move the stock. Monitor for any upcoming corporate events (earnings, pipeline updates) that could provide context for the buying.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
TNXP ▲ +11.37% at T+60d
NEUTRAL call +11.37% · α vs SPY +10.37% · entry $11.52 → $12.83
Entry = T+0 close
Jun 15, 2026
via day close
T+1d
+0.95%
call +0.95% · α +1.55%
$11.63
settled 4mo ago
T+5d
+5.90%
call +5.90% · α +7.29%
$12.20
settled 4mo ago
T+20d
+1.61%
call +1.61% · α +2.36%
$11.71
settled 3mo ago
T+60d
+11.37%
call +11.37% · α +10.37%
$12.83
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Three insiders including CEO Seth Lederman made small open-market purchases totaling $132K, representing ~0.07% of TNXP's $181M market cap. While insider buying is generally positive, the dollar amounts are trivial relative to company size, and historical patterns on TNXP show poor predictive accuracy for such signals. The cluster is likely routine portfolio adjustments rather than a strong conviction signal.

Key Financial Metrics

Direction
buying
Total Value
$132.0K
Insiders
3

Key Facts

  • CEO Seth Lederman bought 5,000 shares at $11.79 ($59K) on 2026-06-09
  • Director Carolyn Taylor bought 1,415 shares at $10.55 ($15K) on 2026-06-12
  • Director Richard Stillwell bought 5,000 shares at $11.65 ($58K) on 2026-06-08
  • Total insider purchases of $132K represent ~0.07% of market cap

Financial Impact

Insider purchases totaling $132K, less than 0.1% of market cap

insider buyingmarket cap

Risk Factors

  • Insider buying may be routine portfolio rebalancing
  • Historical insider signals at TNXP have not been predictive
  • Company is a pre-revenue biotech with high volatility

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TNXP-1781521246008
28 reports for TNXP
Performance horizon
67% Hit rate @ T+20 6 of 9 directional calls Went positive at some point 8 of 11 best @ T+20▲ +32.15%Aug 3, 2026
Filters
Rows
Reports for TNXP — sortable, filterable
TypeNow
Oct 19, 2026
8d ago
Press Release
NEUTRAL ★ 3/10
$5.73awaiting T+20—$5.39 (−5.93%)
Oct 15, 2026
12d ago
8-K
BULLISH ★ 5/10
$6.42awaiting T+20—$5.39 (−16.04%)
Oct 2, 2026
24d ago
8-K
BEARISH ★ 6/10
$8.07awaiting T+20—$5.39 (+33.21%)
Sep 22, 2026
5w ago
8-K
BULLISH ★ 5/10
$10.59 $5.78▼ −45.42%▼ −44.86%$5.39 (−49.10%)
Sep 8, 2026
7w ago
8-K
NEUTRAL ★ 2/10
$13.16 $7.70▼ −41.49%▼ −43.46%$5.39 (−59.04%)
Aug 10, 2026
11w ago
8-K
BULLISH ★ 6/10
$12.59 $13.16▲ +4.53%▲ +5.44%$5.39 (−57.19%)
Aug 10, 2026
11w ago
Press Release
MIXED ★ 6/10
$12.59 $13.16▲ +4.53%▲ +5.44%$5.39 (−57.19%)
Aug 3, 2026
12w ago
8-K
BULLISH ★ 6/10
$10.67 $14.10▲ +32.15%▲ +30.91%$5.39 (−49.48%)
Jul 27, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$10.37 $12.45▲ +20.06%▲ +16.76%$5.39 (−48.02%)
Jul 13, 2026
15w ago
8-K
BULLISH ★ 6/10
$11.71 $12.59▲ +7.56%▲ +4.38%$5.39 (−53.95%)
Showing 10 of 28

US Market Status

Market Closed — Opens Wed (17h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 15, 2026